Abstract. The role of fibroblast growth factor 2 (FGF2) secretion by vascular endothelial cells during trophoblast invasion was assessed. The human extravillous trophoblast cell line, TEV-1, and umbilical vein endothelial cell line, HUVE-12, were cocultured under normal and hypoxic conditions. FGF2 expression in HUVE-12 cells and matrix metalloproteinase 9 (MMP9) and tissue inhibitor of metalloproteinase 1 (TIMP1) expression in TEV-1 cells were analyzed using quantitative RT-PCR and Western blot analyses. TEV-1 cell invasion was also examined. FGF2 expression in the HUVE-12 cells cocultured with TEV-1 cells was significantly increased under hypoxic conditions. In the TEV-1 cells cocultured with HUVE-12, hypoxia reduced MMP9 expression and increased TIMP1 expression; it also reduced cell invasion by 43%. However, the expression of MMP9 and TIMP1 and ratio of MMP9/TIMP1 were increased when the TEV-1 cells were cultured alone under hypoxic conditions. These findings suggest that FGF2 release by stressed endothelial cells of uterine spiral arteries play roles in decreasing MMP9 and increasing TIMP1 production in extravillous trophoblasts (EVT) in response to stress, resulting in reduced EVT invasion and possibly shallow implantation of the placenta. Key words: Basic fibroblast growth factor 2, Extravillous trophoblast, Matrix metalloproteinase 9, Placenta invasion, Tissue inhibitor of metalloproteinase 1 (J. Reprod. Dev. 57: [84][85][86][87][88][89][90][91] 2011) ormal placental development is characterized by uterine spiral artery remodeling through extravillous trophoblast (EVT) invasion of the uterine spiral arteries and the rebuilding process [1] . Impaired uterine spiral artery remodeling and reduced trophoblast invasion is associated with susceptibility to preeclampsia. This pathological state is often manifested as shallow implantation of the placenta [2] .
(J. Reprod. Dev. 57: 84-91, 2011) ormal placental development is characterized by uterine spiral artery remodeling through extravillous trophoblast (EVT) invasion of the uterine spiral arteries and the rebuilding process [1] . Impaired uterine spiral artery remodeling and reduced trophoblast invasion is associated with susceptibility to preeclampsia. This pathological state is often manifested as shallow implantation of the placenta [2] .
Matrix metalloproteinases (MMPs) belong to the neutral protease family, which degrades extracellular matrix. MMPs are regulated by tissue inhibitor of metalloproteinases (TIMPs). Among the identified MMPs, matrix metalloproteinase 9 (MMP9) plays an important role in a series of physiological and pathological processes, including implantation, wound healing, angiogenesis and tumor metastasis [3] . MMP9 is principally regulated by endogenous TIMP1; therefore, the MMP9-TIMP1 balance plays an essential and rate-limiting role in the invasion of trophoblast cells [4, 5] . Abnormal expression of MMP9 by EVTs can result in shallow trophoblast invasion and thus impaired uterine spiral artery remodeling, which is associated with several diseases of pregnancy, including preeclampsia [6] . In order to understand the pathogenesis of preeclampsia, analysis of factors that may influence the MMP9-TIMP1 balance in EVTs is necessary.
Many angiogenic factors can regulate the secretion of MMP9 in trophoblast cells. Anteby et al. [7] observed that exogenous vascular endothelial growth factor (VEGF), epidermal growth factor (EGF), fibroblast growth factor 4 (FGF4) and fibroblast growth factor 10 (FGF10) promoted trophoblast secretion of MMP9; however, basic fibroblast growth factor 2 (FGF2) inhibited it. In patients with preeclampsia, systemic small artery spasm leads to maternal endothelial cell damage and stress response, resulting in the production of a series of angiogenic factors, including VEGF [8, 9] , EGF [10] [11] [12] and FGF2 [13] .
Angiogenic factors have a protective role in repairing damaged endothelial cells; however, few reports have assessed their effects on EVT invasion. Therefore, in the present study, we hypothesized that shallow placenta invasion was mediated by reduced MMP9 expression and was related to FGF2 production by vascular endothelial cells under hypoxic conditions. To test this hypothesis, a human umbilical vein endothelial cell line, HUVE-12, was cocultured with an EVT cell line, TEV-1, and maintained under twodimensional hypoxic conditions in vitro, thereby simulating the in vivo hypoxic environment of uterine spiral artery endothelial cells and trophoblast cells in preeclampsia. The association of FGF2 expression by HUVE-12 cells and MMP9 and TIMP1 expression by TEV-1 cells as well as TEV-1 invasion was explored. Determining the factors involved in endothelial cell repair and trophoblast invasion may provide new targets for the treatment of preeclampsia.
Materials and Methods

Cell conditions
The human EVT cell line, TEV-1 (a gift from the Chinese University of Hong Kong, which first set up this cell line, Hong Kong, China), was derived from primary trophoblast cells isolated from human placental villi early in a normal pregnancy, which were subsequently immortalized through transfection with a retroviral vector expressing human papillomavirus type 16 (HPV16) E6/E7 oncoproteins (PLXSN-E6/E7) [14] . The EVT properties and invasion potential of these cells have been characterized, but no malignant transformation capability has been observed [14] . TEV-1 cells were cultured in Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12) medium purchased from HyClone (Logan, UT, USA) with 5% fetal bovine serum (FBS) purchased from Hangzhou Sijiqing Biological Engineering Material (Hangzhou, Zhejiang, China); no antibiotics were added. Human umbilical vein endothelial cells (HUVE-12) were purchased from Xiangya Central Laboratory (Changsha, Hunan, China), which purchased the HUVE-12 from ATCC (Manassas, VA , USA). The HUVE-12 cells were cultured and maintained in DMEM/F12 medium with 5% FBS without antibiotics. All cells were cultured at 37 C in a humidified incubator containing 5% CO2 in air.
For cocultures, a 2-ml sample of TEV-1 cell suspension (5 × 10 4 cells/ml in DMEM/F12 medium supplemented with 5% FBS) was added in the upper chamber of a Transwell (0.4 μm aperture and 24-mm membrane diameter; 6-well plate, Corning Costar, Lowell, MA, USA), and a 1-ml HUVE-12 cell suspension (1 × 10 4 cells/ml in DMEM/F12 supplemented with 5% FBS) was added to the lower chamber. The medium was replaced after 24 h. Upon reaching 70% confluency, the cells were divided into two groups: a normal control group and a hypoxia group that received cobalt chloride (150 μM) in the upper and lower chambers. Cobalt chloride interferes with iron (heme) interaction with oxygen [15] . The cells in the upper and lower chambers were collected at 24, 48 and 72 h, and quantitative RT-PCR and Western blot analyses were used to detect MMP9 and TIMP1 expression in the TEV-1 cells in the upper chamber and FGF2 expression in the HUVE-12 cells in the lower chamber. In another experiment, the TEV-1 cells were cultured alone under normal and hypoxic conditions for various lengths of time (24, 48 and 
Quantitative RT-PCR
After the cells were collected, 1 ml of Trizol purchased from Invitrogen (Carlsbad, CA, USA) was added, and the total RNA was extracted using the phenol-chloroform extraction method. After removing the genomic DNA, cDNA was synthesized using an RTcDNA Kit (Fermentas, Burlington, ON, Canada) following the manufacturer's instructions. FGF2, MMP9, TIMP1 and β-actin mRNA was amplified using the following primers: 5'-CTAAC-CGTTACCTGGCTATG-3', sense, and 5'-TTATACTGCCCA-GTTCGTTT-3', antisense, for FGF2 (166 bp); 5'-GCAGAG-GAATACCTGTACCGC-3', sense, and 5'-AGGTTTGGAATC-TGCCCAGGT-3', antisense, for MMP9 (196 bp); 5'-CACCT-TATACCAGCGTTATGA-3', sense, and 5'-GAGAAACTCCTC-GCTGCGGTT-3', antisense, for TIMP1 (157 bp); and 5'-CAT-TAAGGAGAAGCTGTGCT-3', sense, and 5'-GTTGAAGGT-AGTTTCGTGGA-3 ', antisense, for β-actin (208 bp; Invitrogen).
In the amplification reaction, 1 μl of template, 100 nM (final concentration) each of the sense and antisense primers, 12.5 μl of SYBR Green PCR Master Mix (ABI, Foster City, CA, USA) and 9.5 μl of dd2H2O were combined. The amplification conditions consisted of the following cycles: 1 cycle of predegeneration at 95 C for 5 min and 45 cycles of denaturation at 94 C for 20 sec, annealing at 55 C for 20 sec and extension at 72 C for 20 sec. The ratio of the target gene to the internal reference (ΔCt) was obtained, and the sample with the lowest content was used as the standard. The contents of the remaining samples were relative multiples of those samples (ΔΔCt), and the target gene mRNA was the relative quantitative value (2 -ΔΔCt ) [16] .
Western blot analysis
At the end of the culture period, cells were washed with ice-cold PBS and lysed by sonication in lysis buffer (RIPA, ProMab Biotechnologies, Richmond, CA, USA). Insoluble material was removed by centrifugation (12000 × g, 4 C, 10 min), and the protein content in the supernatant was determined using a BCA Protein Assay Kit purchased from Beyotime Institute of Biotechnology (Shanghai, China). Aliquots of protein (10 μg) were resolved by SDS-PAGE and electrotransferred to nitrocellulose membranes. The membranes were incubated for 2 h at room temperature in blocking buffer (Tris-buffered saline, pH 7.6, 0.05% Tween-20 [TBS-T] and 0.5% dehydrated non-fat milk). After rinsing with TBS-T, membranes were immunoblotted with primary antibodies specific for FGF2, MMP9, TIMP1 or GAPDH (Beijing Seajet Scientific, Beijing, China) for one hour at room temperature. After rinsing with TBS-T, the goat anti -mouse IgG secondary antibodies conjugated with horseradish peroxidase, purchased from Maxim Biotechnology (Fuzhou, Fujian, China), were added for binding by incubation at room temperature for one hour. The bands were visualized using ECL reagents (Thermo Scientific Pierce, Rockford, IL, USA) and quantified with the Gel-Pro Analyzer software (Gel-Pro Version 4.0, Media Cybernetics, Bethesda, MD, USA) for the relative protein band optical density (OD) reading.
Invasion analysis
Cell invasion assays were performed according to the method established by Sato et al. [17] ; the filter membrane surface of the Transwell plate (8-μm aperture and 24-mm membrane diameter, 6-well plate, Corning Costar) was coated with 50 mg/l Matrigel (Sigma, St. Louis, MO, USA) diluted at a ratio of 1:8 (100 μl/aperture), which was placed at 37 C for 30 min. A 2-ml sample of TEV-1 cells (5 × 10 4 cells/ml in DMEM/F12 medium containing 0.2% BSA) was added to the upper chamber of the Transwell, and in the coculture model, 1 ml of HUVE-12 cells (1 × 10 4 cells/ml in DMEM/F12 containing 5% FBS) was added to the lower chamber. After 24 h, the TEV-1 cells from coculture with the HUVE-12 cell model or culture alone model were divided into two groups: the normal control group and the hypoxia group that received cobalt chloride (150 μM) in the upper and lower chambers. The cells were cultured in air containing 5% CO2 at 37 C for 72 h. A cotton swab was used to wipe the cells and Matrigel in the upper chamber; only those cells that penetrated through the membrane were retained. The cells were fixed with 95% alcohol for 15-20 min, and they were then stained with hematoxylin for 10 min. Immunocytochemistry analysis of the lower chamber was undertaken to confirm the absence of TEV-1 cell migration into the lower chamber (data not shown). Five visual fields were randomly selected from each aperture using an inverted microscope (300× magnification), and the cells were counted; an average cell count was calculated.
Statistical analyses
Data were described as means and standard deviations of three separate experiments. The comparisons were performed using ttests and ANOVA with Bonferroni adjustment. Data were analyzed using the SAS 9.0 statistical software (SAS Institute, Cary, NC, USA). All P-values were two-sided, and differences were considered significant if the P-value was less than 0.05.
Results
Effects of hypoxia on FGF2 expression in HUVE-12 cells cocultured with TEV-1 cells
We first detected FGF2 expression in HUVE-12 cells cocultured with TEV-1 cells under hypoxia conditions. As determined by quantitative RT-PCR analysis, relative FGF2 mRNA expression was significantly elevated in cells maintained under hypoxic conditions for 24, 48 and 72 h as compared with those cultured under control conditions (Fig. 1, all P<0 .05). The highest expression of FGF2 mRNA was observed in the hypoxia group at 72 h. In addition, Western blot analysis revealed that FGF2 protein expression was significantly higher in the hypoxia group at each time point as compared with the control group (Fig. 2, all, P<0 .05). These results suggest that hypoxia conditions stimulate FGF2 expression in both mRNA and protein in HUVE-12 cells cocultured with TEV-1 cells.
Effects of hypoxia on MMP9 and TIMP1 expression in TEV-1 cells cocultured with HUVE-12 cells
Next, we wanted to know whether MMP9 and TIMP1 expression by extravillous trophoblast cells cocultured with endothelial cells is also affected under hypoxic conditions. As shown in Figs. 3 and 4, significantly lower MMP9 mRNA and protein expression, respectively, was observed in cells cultured under hypoxic condi- To determine whether the hypoxic conditions could directly affect MMP9 and TIMP-1 expression of TEV-1 cells, TEV-1 cells were cultured alone under hypoxic conditions, and then the MMP9 and TIMP-1 mRNA levels were determined ( Table 1 ). The mRNA levels of both MMP9 and TIMP1 were upregulated in TEV-1 cells cultured alone under hypoxic conditions, and an increased MMP9/ TIMP1 ratio was also observed, indicating that downregulation of MMP9 in TEV-1 cell cocultures maintained under hypoxic conditions was not caused by hypoxia itself (Table 1) . These results indicate that hypoxia increases TIMP1 expression while reducing MMP9 expression in TEV-1 cells cocultured with HUVE-12 cells.
Effects of hypoxia on invasion of TEV-1 cells cocultured with HUVE-12 cells
Because cytotrophoblasts acquire an invasive phenotype upon culture on Matrigel [18] , TEV-1 cell invasion in response to HUVE-12 cell coculture and hypoxia was determined using Matrigel invasion assays. Reduced cell invasion was observed in TEV-1 cells grown under hypoxic coculture conditions as compared with those maintained under control conditions (Fig. 5A) . Specifically, the average number of invasive cells per visual field was 50.8 ± 4.5 in the control group and 29.6 ± 3.9 in the hypoxia group, representing a 43% reduction in cell invasion (Fig. 5B, P<0.05) . Furthermore, to determine whether altered TEV-1 cell invasion was due to the secretion of a soluble factor from HUVE-12 cells or in response to hypoxia, analysis of TEV-1 cell invasion in TEV-1 cells cultured under hypoxic conditions only was carried out. In response to hypoxia, increased TEV-1 cell invasion was observed (Fig. 5A) . Specifically, the average number of invasive TEV-1 cells increased by about 120% under the hypoxia only culture con- MMP9 and TIMP1 expression was normalized to β-actin in all samples, and relative MMP9 and TIMP1 mRNA expression was determined using the ΔΔCt method. *P<0.05 compared with the control group at each time point; †P<0.05 compared with the 24 -h group. ‡P<0.05 compared with the 48-h group. 
Discussion
Using cocultures of HUVE-12 and TEV-1 cells maintained under normal or hypoxic conditions, we observed elevated FGF2 expression in HUVE-12 cells in response to hypoxia. In TEV-1 cells, reduced MMP9 and elevated TIMP1 levels were detected in cells subjected to hypoxia; decreased cell invasion was also observed.
The cytotrophoblast cell columns and cytotrophoblastic shell around the entire embryo at early stage of gestation consist of EVTs [19] . EVT invasion into the uterine spiral arteries and the rebuilding process is known as uterine spiral artery remodeling, which is crucial for normal placental development [1] . In normal pregnancy, EVT invasion occurs during two peak periods; the first peak takes place within 10 weeks in early pregnancy. At that time, EVTs invade the vascular wall and extend in a retrograde manner to the decidual-myometrial junction. Simultaneously, muscle and elastic fiber damage in the vascular media and deposition of a fibrin-like substance occur, and these changes are the physiological changes of the uterine spiral arteries during pregnancy [1] . The second invasion occurs within 14 to 20 weeks of gestation, at which time vascular physiological changes of the myometrial segment of the spiral artery have been observed, and sometimes the end of the radiate artery is involved [19] , inducing progressive dilation of the spiral artery and increasing placental and fetal blood supply. The second peak of EVT invasion is absent in patients with preeclampsia [20] . Because the myometrial segment of the spiral artery remains unchanged, the lumen of the spiral arteries remains small, and the arteries are rich in elastic fibers. This pathological state is often manifested as shallow implantation of the placenta.
The mechanism of shallow implantation is not fully understood. In part, limited information has been obtained from animal models, as spiral artery remodeling is unique to human pregnancy [21, 22] . Studies using human spiral arteries generally rely on placental biopsy, histochemical or immunohistochemical analysis on resected uterus specimens [23] [24] [25] [26] [27] [28] [29] [30] [31] ; however, histological analyses only reflect the condition of specimens at a certain time and location, thereby providing very limited information concerning the mechanism of the remodeling process. In addition, use of single cells does not fully reflect the in vivo microenvironment. To better simulate the in vivo hypoxic environment of the spiral artery endothelial cells and trophoblasts in preeclampsia, we cocultured the human umbilical vein endothelial cell line, HUVE-12, and EVT cell line, TEV-1, in two-dimensional hypoxic conditions in vitro. This experimental model may provide a basis to determine the mechanism of shallow implantation in preeclampsia. Preeclampsia generally occurs after 20 weeks of gestation and causes systemic small artery spasms that lead to maternal endothelial damage and stress response, resulting in the production of a series of angiogenic factors, including VEGF [8, 9] , EGF [10] [11] [12] and FGF2 [13] . Those angiogenic factors have a role in repairing damaged endothelial cells, but their effects on the invasiveness of extravillous trophoblast cells have yet to be determined. Compared with other angiogenic cytokines such as VEGF, FGF2 induces endothelial cell proliferation to a greater extent [32] . Many embryonic germ layer-derived cells and endothelial cells themselves secrete FGF2 [33] , which may maintain endothelial cell growth via autocrine and paracrine signaling. FGF2 binds heparan sulfate within the extracellular matrix of basement membrane cells and is stored within the tissue. During tissue ischemia and hypoxia, extracellular matrix damage induces release of stored FGF2, which may promote proliferation and differentiation of endothelial cells and tissue repair [34, 35] . This is the stress response of endothelial cells in response to hypoxia. In the present study, HUVE-12 cells cultured under hypoxic conditions produced increased FGF2 mRNA and protein levels as compared with cells maintained under normal conditions. However, increased FGF2 expression was obviously associated with duration of hypoxia ( Figs. 1 and 2) . These results are consistent with those reported by Lygnos et al. [13] , who reported observation of elevated serum FGF2 levels in patients with preeclampsia.
MMP9 plays an important role in trophoblast invasion [36] . MMP9 is a proteolytic enzyme that mainly degrades the extracellular matrix. TIMP1 is a specific inhibitor of MMP9; it binds MMP9 through noncovalent bonds in a 1:1 ratio. Therefore, the balance between MMP9 and TIMP1 influences cell infiltration and its ratelimiting steps [4, 5] . In this study, EVTs expressed lower levels of MMP9 mRNA and protein and increased levels of TIMP1 mRNA and protein in response to coculture hypoxic conditions. There was a correlation between the duration of hypoxia and the observed levels of MMP9 and TIMP1 mRNA and protein (Figs. 3 and 4) . Under the same conditions, the invasiveness of EVTs was significantly decreased, indicating that cocultures maintained under hypoxic conditions reduced MMP9 and increased TIMP1 expression, resulting in decreased EVT invasiveness. In addition, analysis of TEV-1 cells alone revealed increased invasion in response to hypoxia (data not shown), indicating that hypoxia induces release of soluble factors such as FGF2 by HUVE-2 cells, resulting in reduced MMP9 expression and TEV-1 cell invasion.
Previous studies comparing levels of plasma MMPs and their inhibitors in normal pregnant and preeclamptic women have reported conflicting results. Some studied found that the plasma MMP2 and TIMP1 levels in preeclamptic pregnant women were higher than those in normotensive pregnant women while the plasma MMP9 level was lower in pregnant women with preeclampsia [37] [38] [39] . The patients with preeclampsia might secret less MMP9 from the placenta. For example, reduced MMP9 levels were observed in placenta extracts from preeclamptic women as compared with normal pregnant women [40] . At the same time, the vascular endothelial cells secreted more MMP2 and TIMP1, which in turn damaged vascular endothelial cells [37, 41] .
The MMP9-TIMP1 balance was negatively correlated with the FGF2 protein levels in HUVE-12 cells, suggesting that vascular endothelial cell production of FGF2 may participate in MMP9/ TIMP1 regulation. The influence of FGF2 on MMP9 in various cell-types has been well-documented; in some cells, it synergistically promotes MMP9 secretion [42] [43] [44] , while in others, it has no effects [45] [46] [47] [48] . Specific cellular characteristics as well as different extracellular environments may determine the FGF2 influence on MMP9. In addition, the exact regulatory mechanism by which FGF2 influences trophoblast MMP9 expression remains unclear. In breast cancer MCF-7 cells, FGF2-mediated MMP9 secretion through Ras/ERK signaling was observed [43] . Further studies are required to determine the signaling mechanism by which FGF2 may influence MMP9 expression in EVTs.
There are some limitations regarding the present study. Firstly, we did not examine the direct effect of FGF2 on MMP9 and TIMP1 expression. It remains possible that other paracrine factors may also mediate MMP9 and TIMP1 expression as well as EVT invasion. Anteby et al. reported that addition of FGF2 to trophoblast cell medium resulted in reduced MMP9 expression [7] . In that study, four other factors, VEGF, EGF, FGF10 and FGF4, also increased MMP9 expression in trophoblasts [7] . Studies using FGF2 siRNA in HUVE-12 cells or FGF2 neutralizing antibodies will be undertaken in the future to determine if FGF2 directly influences MMP9 and TIMP1. In addition, the use of cobalt chloride to mimic hypoxia may be viewed as a study limitation. However, previous studies comparing the effects of cobalt chloride-induced hypoxia with environmental hypoxia found no obvious differences [15, [49] [50] [51] . However, high levels of both MMP9 and TIMP1 in mRNA (Table 1 ) and protein (Luo et al., in press, Acta Medicinae Universitatis Science of Technologiae Huazhong, April 2010, Volume 2) were observed in TEV-1 cells cultured alone under hypoxic conditions. Thus, altered MMP9 and TIMP1 expression was not due to hypoxia but rather signaling factors associated with coculture, which is consistent with a previous study that observed decreased MMP9 expression by cytotrophoblasts in response to coculture with endothelial cells [5] . The use of endothelial and cytotrophoblasts cell lines rather than primary cultures represents another study limitation. However, the TEV-1 cell line displays similar functions as compared with normal extravillous trophoblasts, and they do not have the malignant invasive capability of the villous tumor cell lines, BeWo, JEG and JAR [14] . In addition, HUVE-12 cells, which are frequently used to analyze angiogenesis, also respond to hypoxia [52] .
In summary, the coculture model better simulates the in vivo environment of preeclampsia. Thus, it may help further our understanding of maternal-fetal cell interactions, which may provide a theoretical basis for the hypothesis that maternal cells control the invasion of EVTs. In addition, the results of this study suggest that although hypoxia-induced FGF2 production by vascular endothelial cells may induce repair of maternal blood vessels, it downdownregulates MMP9 secretion by EVTs and decreases their invasiveness, thereby possibly aggravating preeclampsia. Therefore, for clinical treatment of preeclampsia, simultaneous repair of vascular endothelial cell function and improvement of cytotrophoblast invasiveness should be considered in order to achieve satisfactory practical results.
